Gene expression profile of mitogen-activated kinases and microRNAs controlling their expression in HaCaT cell culture treated with lipopolysaccharide A and cyclosporine A

References

• Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475. doi: 10.3390/ijms20061475
   PubMed Web of Science ®Google Scholar
• Lories RJU, Derese I, Luyten FP, et al. Activation of nuclear factor kappa B and mitogen activated protein kinases in psoriatic arthritis before and after etanercept treatment. Clin Exp Rheumatol. 2008;26(1):96–102.
   PubMed Web of Science ®Google Scholar
• Baran A, Nowowiejska J, Kamiński TW, et al. Circulating MAdCAM-1 and ITGB7 in patients with plaque psoriasis and eruptive lichen planus—preliminary data. Biology. 2021;10(11):1129. doi: 10.3390/biology10111129
   PubMedGoogle Scholar
• Griffiths CEM, Armstrong AW, Gudjonsson JE, et al. Psoriasis. Lancet Lond Engl. 2021;397(10281):1301–1315. doi: 10.1016/S0140-6736(20)32549-6
   PubMed Web of Science ®Google Scholar
• Foks-Ciekalska A, Jarząb J, Bożek A, et al. The vicious circle effect: stress as effect and cause in patients with psoriasis. Postepy Dermatol Alergol. 2023;40(3):362–367. doi: 10.5114/ada.2022.120452
   PubMed Web of Science ®Google Scholar
• Tripathi R, Liu Z, Jain A, et al. Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling. Nat Commun. 2020;11(1):5463. doi: 10.1038/s41467-020-19075-3
   PubMed Web of Science ®Google Scholar
• Reich A, Adamski Z, Chodorowska G, et al. Psoriasis. Diagnostic and therapeutic recommendations of the Polish dermatological society. Part 2. Dermatol Rev Dermatol. 2020;107(2):110–137. doi: 10.5114/dr.2020.95259
   Google Scholar
• Reich A, Adamski Z, Chodorowska G, et al. Psoriasis. Diagnostic and therapeutic recommendations of the Polish dermatological society. Part 1. Dermatol Rev Dermatol. 2020;107(2):92–108. doi: 10.5114/dr.2020.95258
   Google Scholar
• Xhaja A, Shkodrani E, Frangaj S, et al. An epidemiological study on trigger factors and quality of life in psoriatic patients. Mater Socio Medica. 2014;26(3):168–171. doi: 10.5455/msm.2014.26.168-171
   PubMedGoogle Scholar
• Hervé F, Bakchine H, Le Loc’h H, et al. Hemorrhagic shock syndrome with encephalopathy. Arch Fr Pediatr. 1987;44(3):195–197.
   PubMedGoogle Scholar
• Cho SH, Kim HS, Lee W, et al. Eckol from ecklonia cava ameliorates TNF-α/IFN-γ-induced inflammatory responses via regulating MAPKs and NF-κB signaling pathway in HaCaT cells. Int Immunopharmacol. 2020;82:106146. doi: 10.1016/j.intimp.2019.106146
   PubMed Web of Science ®Google Scholar
• Yildiz A, Kaya Y, Yildiz A, et al. Post-translational regulation of the activity of ERK/MAPK and PI3K/AKT signaling pathways in neuroblastoma cancer. Post-translational modifications in cellular functions diseases. IntechOpen. 2021. doi:10.5772/intechopen.96176.
   Google Scholar
• Yue J, López JM. Understanding MAPK Signaling Pathways in Apoptosis. Int J Mol Sci. 2020;21(7):2346. doi: 10.3390/ijms21072346
   PubMed Web of Science ®Google Scholar
• Zou J, Lei T, Guo P, et al. Mechanisms shaping the role of ERK1/2 in cellular senescence (review). Mol Med Rep. 2019;19(2):759–770. doi: 10.3892/mmr.2018.9712
   PubMed Web of Science ®Google Scholar
• Pua LJW, Mai CW, Chung FFL, et al. Functional roles of JNK and p38 MAPK signaling in nasopharyngeal carcinoma. Int J Mol Sci. 2022;23(3):1108. doi: 10.3390/ijms23031108
   PubMed Web of Science ®Google Scholar
• Ganguly P, Macleod T, Wong C, et al. Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in inflammatory arthritis: a narrative of the emergence of MAPK-Activated Protein kinase inhibitors (MK2i). Pharmaceuticals. 2023;16(9):1286. doi: 10.3390/ph16091286
   Web of Science ®Google Scholar
• Yu XJ, Li CY, Dai HY, et al. Expression and localization of the activated mitogen-activated protein kinase in lesional psoriatic skin. Exp Mol Pathol. 2007;83(3):413–418. doi: 10.1016/j.yexmp.2007.05.002
   PubMed Web of Science ®Google Scholar
• Guo J, Zhang H, Lin W, et al. Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther. 2023;8(1):1–38. doi: 10.1038/s41392-023-01655-6
   PubMed Web of Science ®Google Scholar
• Lai B, Wu CH, Lai JH. Activation of c-Jun N-Terminal Kinase, a potential therapeutic target in autoimmune arthritis. Cells. 2020;9(11):2466. doi: 10.3390/cells9112466
   PubMed Web of Science ®Google Scholar
• Grabarek BO, Dąbala M, Kasela T, et al. Changes in the expression pattern of DUSP1-7 and miRNA regulating their expression in the keratinocytes treated with LPS and adalimumab. Curr Pharm Biotechnol. 2022;23(6):873–881. doi: 10.2174/1389201022666210802102508
   PubMed Web of Science ®Google Scholar
• Kasela T, Dąbala M, Mistarz M, et al. Effects of cyclosporine a and adalimumab on the expression profiles histaminergic system-associated genes and microRnas regulating these genes in HaCaT cells. Cell Cycle. 2022;0(0):1–18. doi: 10.1080/15384101.2022.2103342
   Google Scholar
• Adwent I, Grabarek BO, Kojs-Mrożkiewicz M, et al. The influence of adalimumab and cyclosporine a on the expression profile of the genes related to TGFβ signaling pathways in keratinocyte cells treated with lipopolysaccharide A. Mediators Inflamm. 2020;2020:3821279. doi: 10.1155/2020/3821279
   PubMed Web of Science ®Google Scholar
• Grabarek BO, Kasela T, Adwent I. et al. Evaluation of the influence of adalimumab on the expression profile of leptin-related genes and proteins in keratinocytes treated with lipopolysaccharide A. Int J Mol Sci. 2021 [cited 2021 Feb 5];22(4):1595. doi: 10.3390/ijms22041595
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam JW, et al. Predicting effective microRNA target sites in mammalian mRnas. In: Izaurralde E, editor eLife. Vol. 4. 2015; p. e05005. doi:10.7554/eLife.05005
   Google Scholar
• Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. Nucleic Acids Res. 2020;48(D1):D127–D131. doi: 10.1093/nar/gkz757
   PubMed Web of Science ®Google Scholar
• Liu W, Wang X. Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data. Genome Biol. 2019;20(1):18. doi: 10.1186/s13059-019-1629-z
   PubMed Web of Science ®Google Scholar
• Rouillard AD, Gundersen GW, Fernandez NF, et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database J Biol Databases Curation. 2016;2016:baw100. doi: 10.1093/database/baw100
   PubMedGoogle Scholar
• Gupta R. Prolonged remission of psoriasis with azathioprine pulse therapy. Indian J Dermatol. 2015;60(4):360–363. doi: 10.4103/0019-5154.160480
   PubMed Web of Science ®Google Scholar
• Bowcock AM. The genetics of psoriasis and autoimmunity. Annu Rev Genomics Hum Genet. 2005;6(1):93–122. doi: 10.1146/annurev.genom.6.080604.162324
   PubMedGoogle Scholar
• Ran D, Cai M, Zhang X. Genetics of psoriasis: a basis for precision medicine. Precis Clin Med. 2019;2(2):120–130. doi: 10.1093/pcmedi/pbz011
   PubMedGoogle Scholar
• Gunter NV, Yap BJM, Chua CLL, et al. Combining understanding of immunological mechanisms and genetic variants toward development of personalized medicine for psoriasis patients. Front Genet. 2019;10:395. doi: 10.3389/fgene.2019.00395
   PubMed Web of Science ®Google Scholar
• Vide J, Magina S. Moderate to severe psoriasis treatment challenges through the era of biological drugs. An Bras Dermatol. 2017;92(5):668–674. doi: 10.1590/abd1806-4841.20175603
   PubMed Web of Science ®Google Scholar
• Piragine E, Petri D, Martelli A, et al. Adherence and persistence to biological drugs for psoriasis: systematic review with meta-analysis. J Clin Med. 2022;11(6):1506. doi: 10.3390/jcm11061506
   PubMed Web of Science ®Google Scholar
• Ożóg MK, Grabarek BO, Wierzbik-Strońska M, et al. Neurological complications of biological treatment of psoriasis. Life Basel Switz. 2022;12(1):118. doi: 10.3390/life12010118
   PubMed Web of Science ®Google Scholar
• Nadal-Ribelles M, Solé C, Martínez-Cebrián G, et al. Shaping the transcriptional landscape through MAPK signaling. Gen Exp Cont. 2018. IntechOpen. doi: 10.5772/intechopen.80634
   Google Scholar
• Cohen SB, Cheng TT, Chindalore V, et al. Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis. Arthritis Rheum. 2009;60(2):335–344. doi: 10.1002/art.24266
   PubMed Web of Science ®Google Scholar
• Lee JK, Kim NJ. Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer’s disease. Mol J Synth Chem Nat Prod Chem. 2017;22(8):1287. doi: 10.3390/molecules22081287
   Google Scholar
• Marber MS, Rose B, Wang Y. The p38 mitogen-activated protein kinase pathway–a potential target for intervention in infarction, hypertrophy, and heart failure. J Mol Cell Cardiol. 2011;51(4):485–490. doi: 10.1016/j.yjmcc.2010.10.021
   PubMed Web of Science ®Google Scholar
• Krawczyk A, Strzałka-Mrozik B, Grabarek B, et al. mRNA level of ROCK1, RHOA, and LIMK2 as genes associated with apoptosis in evaluation of effectiveness of adalimumab treatment. Pharmacol Rep PR. 2020;72(2):389–399. doi: 10.1007/s43440-020-00068-4
   PubMed Web of Science ®Google Scholar
• Tan Y, Qi Q, Lu C, et al. Cytokine imbalance as a common mechanism in both psoriasis and rheumatoid arthritis. Mediators Inflamm. 2017;2017:2405291. doi: 10.1155/2017/2405291
   PubMed Web of Science ®Google Scholar
• Chen HF, Chuang HC, Tan TH. Regulation of dual-specificity phosphatase (DUSP) ubiquitination and protein stability. Int J Mol Sci. 2019;20(11):2668. doi: 10.3390/ijms20112668
   PubMed Web of Science ®Google Scholar
• Kjellerup RB, Johansen C, Kragballe K, et al. The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin. Br J Dermatol. 2013;168(2):339–345. doi: 10.1111/bjd.12020
   PubMed Web of Science ®Google Scholar
• Chen H, Xiong Y, Liu L, et al. MicroRNA-34a inhibits proliferation and stimulates apoptosis in human keratinocyte through activation of smac-mediated mitochondrial apoptotic pathway: a potential therapeutic target for psoriasis. Int J Clin Exp Pathol. 2017; 10:266–273.
   Web of Science ®Google Scholar
• Wang H, Zhang X, Bu J, et al. Regulation of notch1 and foxp1 by MiR-34a in psoriasis vulgaris. Int J Morphol. 2022;40(3):735–741. doi: 10.4067/S0717-95022022000300735
   Web of Science ®Google Scholar
• Gang L, Qun L, Liu WD, et al. MicroRNA-34a promotes cell cycle arrest and apoptosis and suppresses cell adhesion by targeting DUSP1 in osteosarcoma. Am J Transl Res. 2017; 9(12):5388.
   PubMed Web of Science ®Google Scholar
• Li Y, Shao J, Song J, et al. MiR-34a-3p suppresses pulmonary vascular proliferation in acute pulmonary embolism rat by targeting DUSP1. Biosci Rep. 2022;42(1):BSR20210116. doi: 10.1042/BSR20210116
   PubMed Web of Science ®Google Scholar
• Parveen S, Chowdhury AR, Jawed JJ, et al. Immunomodulation of dual specificity phosphatase 4 during visceral leishmaniasis. Microbes Infect. 2018;20(2):111–121. doi: 10.1016/j.micinf.2017.10.009
   PubMed Web of Science ®Google Scholar
• Cornell TT, Rodenhouse P, Cai Q, et al. Mitogen-activated protein kinase phosphatase 2 regulates the inflammatory response in sepsis. Infect Immun. 2010;78(6):2868–2876. doi: 10.1128/IAI.00018-10
   PubMed Web of Science ®Google Scholar
• Dougherty JA, Kilbane Myers J, Khan M, et al. Dual-specificity phosphatase 4 overexpression in cells prevents Hypoxia/Reoxygenation-induced apoptosis via the upregulation of eNOS. Front Cardiovasc Med. 2017 [cited 2023 Dec 22];4 doi: 10.3389/fcvm.2017.00022
   PubMed Web of Science ®Google Scholar
• Li Z, Chen B. DUSP4 alleviates LPS-induced chondrocyte injury in knee osteoarthritis via the MAPK signaling pathway. Exp Ther Med. 2021;22(6):1401. doi: 10.3892/etm.2021.10837
   PubMed Web of Science ®Google Scholar
• Wang X, Xue N, Zhao S, et al. Upregulation of miR-382 contributes to renal fibrosis secondary to aristolochic acid-induced kidney injury via PTEN signaling pathway. Cell Death Dis. 2020;11(8):1–15. doi: 10.1038/s41419-020-02876-1
   PubMed Web of Science ®Google Scholar
• Li N, Chen J, Zhao J, et al. MicroRNA-3188 targets ETS-domain protein 4 and participates in RhoA/ROCK pathway to regulate the development of atherosclerosis. Pharm. 2017;72(11):687–693. doi: 10.1691/ph.2017.7686
   Google Scholar
• Dolcino M, Tinazzi E, Pelosi A, et al. Gene expression analysis before and after treatment with adalimumab in patients with ankylosing spondylitis identifies molecular pathways associated with response to therapy. Genes (Basel). 2017;8(4):127. doi: 10.3390/genes8040127
   PubMed Web of Science ®Google Scholar
• Huang L, Guo B, Yan J, et al. CircHSPG2 knockdown attenuates hypoxia-induced apoptosis, inflammation, and oxidative stress in human AC16 cardiomyocytes by regulating the miR-1184/MAP3K2 axis. Cell Stress Chap. 2023;28(2):177–190. doi: 10.1007/s12192-023-01328-x
   PubMed Web of Science ®Google Scholar
• Magenta A, D’Agostino M, Sileno S, et al. The oxidative stress-induced miR-200c is upregulated in psoriasis and correlates with disease severity and determinants of cardiovascular risk. Oxid Med Cell Longev. 2019;2019:8061901. doi: 10.1155/2019/8061901
   PubMed Web of Science ®Google Scholar
• Denninger K, Rasmussen S, Larsen JM, et al. JNK1, but not JNK2, is required in two mechanistically distinct models of inflammatory arthritis. Am J Pathol. 2011;179(4):1884–1893. doi: 10.1016/j.ajpath.2011.06.019
   PubMed Web of Science ®Google Scholar
• Yang J, Do-Umehara HC, Zhang Q, et al. miR-221-5p-mediated downregulation of JNK2 aggravates acute lung injury. Front Immunol. 2021 Accessed December 22, 2023;12. DOI:10.3389/fimmu.2021.700933
   Web of Science ®Google Scholar
• Chong ZX, Yeap SK, Ho WY, et al. Unveiling the tumour-regulatory roles of miR-1275 in cancer. Pathol Res Pract. 2022;230:153745. doi: 10.1016/j.prp.2021.153745
   PubMedGoogle Scholar
• Hashemi Sheikhshabani S, Amini-Farsani Z, Modarres P, et al. In silico identification of potential miRnas -mRNA inflammatory networks implicated in the pathogenesis of COVID-19. Hum Gene. 2023;36:201172. doi: 10.1016/j.humgen.2023.201172
   Google Scholar
• Rasizadeh R, Aghbash PS, Nahand JS, et al. SARS-CoV-2-associated organs failure and inflammation: a focus on the role of cellular and viral microRnas. Virol J. 2023;20(1):179. doi: 10.1186/s12985-023-02152-6
   PubMed Web of Science ®Google Scholar
• Liu JT, Yeh HM, Liu SY, et al. Psoriatic arthritis: epidemiology, diagnosis, and treatment. World J Orthop. 2014;5(4):537–543. doi: 10.5312/wjo.v5.i4.537
   PubMedGoogle Scholar
• Kamata M, Tada Y. Safety of biologics in psoriasis. J Dermatol. 2018;45(3):279–286. doi: 10.1111/1346-8138.14096
   PubMed Web of Science ®Google Scholar
• Nassar K, Grisanti S, Elfar E, et al. Serum cytokines as biomarkers for age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2015;253(5):699–704. doi: 10.1007/s00417-014-2738-8
   PubMed Web of Science ®Google Scholar